Evoke Wealth LLC Purchases New Position in The Allstate Co. (NYSE:ALL)

Evoke Wealth LLC acquired a new stake in The Allstate Co. (NYSE:ALLFree Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,849 shares of the insurance provider’s stock, valued at approximately $261,000.

Other large investors have also modified their holdings of the company. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Allstate in the third quarter valued at approximately $25,000. Private Wealth Management Group LLC purchased a new stake in shares of Allstate during the fourth quarter worth approximately $25,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Allstate during the fourth quarter worth approximately $36,000. Venturi Wealth Management LLC raised its stake in shares of Allstate by 152.7% during the fourth quarter. Venturi Wealth Management LLC now owns 278 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 168 shares during the last quarter. Finally, Bruce G. Allen Investments LLC purchased a new stake in shares of Allstate during the fourth quarter worth approximately $43,000. 76.47% of the stock is owned by institutional investors and hedge funds.

Allstate Stock Up 1.5 %

ALL opened at $167.52 on Monday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.48. The firm has a market cap of $44.21 billion, a P/E ratio of 36.98, a PEG ratio of 1.58 and a beta of 0.51. The Allstate Co. has a 52 week low of $100.57 and a 52 week high of $177.37. The business’s fifty day simple moving average is $169.25 and its 200 day simple moving average is $156.88.

Allstate (NYSE:ALLGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The insurance provider reported $5.13 EPS for the quarter, beating analysts’ consensus estimates of $4.11 by $1.02. The business had revenue of $15.26 billion for the quarter, compared to analyst estimates of $12.76 billion. Allstate had a return on equity of 14.44% and a net margin of 2.31%. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter last year, the company earned ($1.30) earnings per share. As a group, equities research analysts anticipate that The Allstate Co. will post 15.15 EPS for the current fiscal year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, May 31st will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Friday, May 31st. Allstate’s payout ratio is 81.24%.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the sale, the insider now directly owns 63,731 shares of the company’s stock, valued at approximately $10,847,016.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms have recently commented on ALL. UBS Group upped their price target on Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a research note on Monday, February 12th. Piper Sandler upped their price target on Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a research note on Monday, April 1st. HSBC upgraded Allstate from a “hold” rating to a “buy” rating and increased their price objective for the stock from $158.00 to $190.00 in a research report on Thursday, March 28th. Keefe, Bruyette & Woods increased their price objective on Allstate from $181.00 to $189.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Finally, Morgan Stanley increased their price objective on Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $174.59.

Read Our Latest Analysis on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.